Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Date of authorisation: 12/02/2025, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Duaklir Genuair, aclidinium bromide,formoterol, Date of authorisation: 19/11/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Date of authorisation: 27/11/1995, Revision: 53, Status: Authorised

EMEA-003002-PIP04-23

EMEA-002537-PIP02-19

Human medicines European public assessment report (EPAR): Kygevvi, doxecitine,doxribtimine, Date of authorisation: 26/03/2026, Revision: 1, Status: Authorised

Immunogenicity and efficacy of pneumococcal vaccines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 November 2026, 09:00 (CET) to 17 November 2026, 17:00 (CET)

PSUSA/00000078/202601